Please sign in to follow a disease.

Frontometaphyseal dysplasia 2

MONDO:0014935

Any frontometaphyseal dysplasia in which the cause of the disease is a mutation in the MAP3K7 gene.

Also known as: FMD2, Frontometaphyseal dysplasia 2, Frontometaphyseal dysplasia type 2, MAP3K7 frontometaphyseal dysplasia, frontometaphyseal dysplasia 2; FMD2, frontometaphyseal dysplasia caused by mutation in MAP3K7

2 clinical trials for this condition and its sub-types, 2 tagged with Frontometaphyseal dysplasia 2 itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Frontometaphyseal dysplasia (2)

Including sub-types (2) Tagged with Frontometaphyseal dysplasia 2 (2)

Not yet finished but already full! 1 Completed 1

New hope for FSHD: Long-Term drug safety trial underway

Disease control Ongoing

This study is for people with FSHD, a genetic disease that causes muscle weakness. It tests the long-term safety and how well the body tolerates a drug called AOC 1020, given through a vein. About 84 adults who completed a previous study will take part. The main goal is to check …

Phase 2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control

Last updated Jul 16, 2026 00:00 UTC

Frontometaphyseal dysplasia 2

Where it sits in the disease tree

New hope for FSHD: Long-Term drug safety trial underway